学习与工作经历：

1999.08-2004.06,山东大学临床医学本科，2005.08-2010.06 山东大学医学院普通外科硕博连读。

2010.08-至今 山东大学齐鲁医院普外科，副主任医师，研究生导师。

2024.07-至今 山东大学齐鲁医院（青岛）普外科副主任，胃肠胰外科主任，副主任医师，副教授，硕士研究生导师。

研究方向：

胃肠道疾病、胰腺良恶性疾病、腹膜后肿瘤疾病治疗。 

学术/社会兼职：

中国研究型医院学会腹膜后与盆底疾病专业委员会委员

中国医药教育协会罕见病学专业委员会委员

山东省青年医务工作者协会腹腔及腹膜后疑难复杂疾病分会主任委员

山东卫生人力资源管理协会胰腺及腹膜后疾病人才发展专业委员会副主任委员

山东省临床肿瘤学会胰腺癌专委会青委会副主任委员

山东省医师协会胃肠外科医师分会第三届委员会常务委员

山东省研究型医院协会胰腺疾病专业委员会常务委员

山东省医学会普外科学分会胰腺外科学组委员

山东省医师协会神经内分泌肿瘤专业委员会委员

《腹腔镜外科杂志》编委，《中华肿瘤防治杂志》青年编委   

《Digestion and interventional diagnosis and treatment》编委

《Cell and tumor research》编委 

获奖荣誉：

1.  山东省科技进步一等奖(2019)，腹腔镜袖状胃切除术治疗肥胖症和糖尿病技术体系的建立与应用推广,2019.08，山东省科技厅，参与（第五位）。

2.  山东省科技进步二等奖(JB2011-2-113-1)，自制手套装置和悬吊式免气腹经脐单孔腹腔镜技术的临床应用研究，2011.12.07，山东省科技厅，参与（第七位）。

本科生课程：

外科学

研究生课程：

腹腔镜外科学，内镜外科学

1.  山东省自然科学基金委员会，面上项目，ZR2020MH231，新型siRNA纳米药物靶向miR-221-3p治疗胰腺癌的探索研究，2021.01-2023.12，10万元，在研，主持。

2.  山东省重点研发计划，GG201809170321，基于miR-221-3p的1ncRNA-miRNA对话体系在胰腺癌转移中的调控作用及机制，2019.01-2020.12，15万元，已结题，主持。

3.  国家自然科学基金青年科学基金项目，81502051，长链非编码RNA n385229吸附miR-497对胰腺癌化疗耐药表型的调控作用，2016.01-2018.12，21.6万元，已结题，参加。

4.  山东省自然科学基金面上项目，ZR2017MH032，LncRNA-SNHG1/miR-497/FGFR1轴调控胰腺癌转移的作用及机制，2017.08-2020.06，18万元，已结题，参加。

Jiayao Wen#, Susu Huang, Wei He, Yizhuo Yuan, Yanmin Yi, Yabin Zhang, Wencan Zhang, Zhijian Wei, Xiaoye Yang, Guangxi Zhai, Feng Li*, Lei Ye：Sprayable zwitterionic self-assembling powder for postoperative adhesion prevention, Journal Of Controlled  Release, 2025 Jul 27:386:114069. 中科院一区, 5-IF:11.8. 

Yanfeng Du#; Qizheng Li; Yingfei Xin; Chongyang Fu; Qingxue Wang; Lifeng Cao; Jie Xu; Feng Li*; Qingming Ma; Xiaoxiong Wang：Non-invasive transcutaneous energy transfer for implantable self-powered system, Chemical Engineering Journal, 2025 Aug 1:520:165644, ISSN 1385-8947. 中科院一区, 5-IF:13.5.                      

Wei He#; Jiayao Wen; Qiaoying Hu, Yanmin Yi; Zhijian Wei; Xiaoye Yang; Guangxi Zhai; Feng Li*; Lei Ye：The advances in zwitterionic materials and their biomedical applications, International Materials Reviews, 2025 April 19:70: 1–49.中科院一区, 5-IF:20.6.  

Lin Jiang#, Chaolong Liu, Wenyu Wang, Feng Li*, Qingming Ma, Yong Sun：A novel NIR iridium(III) complex-based probe for accurate imaging of mitochondrial biothiols in ferroptosis-mediated lung ischemia-reperfusion injury, Analytica Chimica Acta, 2025 Aug 15:1373: 1–49.中科院二区, 5-IF:5.7. 

Miao-Lin Lei#; Guan-Wei Bi; Xiao-Lin Yin; Yue Wang; Zi-Ru Sun; Xin-rui Guo; Hui-peng Zhang; Xiao-han Zhao; Feng Li*; Yan-Bo Yu：Targeted urinary metabolomics combined with machine learning to identify biomarkers related to central carbon metabolism for IBD, Frontiers in Molecular Biosciences, 2025 August 11:12: 1615047.中科院三区, 5-IF:4.5. 

Jin Pan#, Liuxuan Huang, Peng Sun, Haoquan Tian, Wenguang Yang, Xinyu Fang, Feng Li*, Ke Ma：Verbascoside reverses GABAergic deficits in the prefrontal cortex to alleviate chronic Stress-Induced depression, Psychopharmacology, 2025 Sep 12.中科院三区, 5-IF:3.3. 

Rui Zhao#; Yanmin Yi; Han Liu; Jianwei Xu; Shuhai Chen; Dong Wu; Lei Wang; Feng Li*: RHOF promotes Snail1 lactylation by enhancing PKM2-mediated glycolysis to induce pancreatic cancer cell endothelial–mesenchymal transition, Cancer & Metabolism, 2024 Oct 26;12(1):32 . 中科院三区, 5-IF:5.8. 

Zhang Aijing#; Wang Kaibin; Tian Xiaohan; Chen Shuhai; Xu Jianwei; Liu Han; Wang Lei; Li Feng*: First case report of diagnosis of extrapancreatic solid pseudopapillary tumor with SMA invasion in a 47-year-old man: a case report and literature review, Frontiers in Surgery, 2024 Mar 27;13:1149942. 中科院四区, 5-IF:1.9. 

Li Chengqing#; Fan Zhiyao; Guo Wenyi; Liang Feng; Mao Xincheng; Wu Jiahao; Wang Haodong; Xu Jianwei; Wu Dong; Liu Han; Wang Lei; Li Feng*: Fibrinogen-to-prealbumin ratio: A new prognostic marker of resectable pancreatic cancer, Frontiers in Oncology, 2023 Mar 27;13:1149942. 中科院三区, 5-IF:4.0. 

Feng Li#; Chengqing Li; Wenyi Guo; Xue Meng*: A world-wide systematic review of the primary leiomyosarcoma of inferior vena cava, Asian Journal of Surgery, 2023 Dec;46(12):5983-5984. 中科院三区,5-IF:3.1. 

Jian Wei Xu#; Ye Yan; Lei Wang; Dong Wu; Nai Kuan Ye; Shi Hong Chen; Feng Li*: Marine bioactive compound dieckol induces apoptosis and inhibits growth of human pancreatic cancer cells PANC-1, Journal of Biochemical and Molecular Toxicology, 2021 Feb 35(2);e22648. 中科院三区, 5-IF:3.4. 

Lei Wang#; Jianwei Xu; Ye Yan; Han Liu; Thiruventhan Karunakaran; Feng Li*: Green synthesis of gold nanoparticles from Scutellaria barbata and its anticancer activity in pancreatic cancer cell (PANC-1), Artificial Cells Nanomedicine and Biotechnology, 2019, 47(1): 1617-1627. 中科院二区, 5-IF:4.5. 

Lei Wang#; Jianwei Xu; Ye Yan; Han Liu; Feng Li*: Synthesis of gold nanoparticles from leaf Panax notoginseng and its anticancer activity in pancreatic cancer PANC-1 cell lines, Artificial Cells Nanomedicine and Biotechnology, 2019, 47(1): 1216-1223. 中科院二区, 5-IF:4.5. 

Feng Li#; Jian-Wei Xu; Lei Wang; Han Liu; Ye Yan; San-Yuan Hu*: MicroRNA-221-3p is up-regulated and serves as a potential biomarker in pancreatic cancer, Artificial Cells, Nanomedicine, and Biotechnology, 2018 May; 46(3):482-487. 中科院三区, 5-IF:4.5. 

Xuquan Jing; Feng Li#; Xue Meng; Zhitong Liu; Jinming Yu; Bo Liu*: Ovarian metastasis from lung adenocarcinoma with ALK-positive rearrangement detected by next generation sequencing A case report and literatures review, Cancer Biology & Therapy, 2017 May 4;18(5): 279–284. 中科院二区, 5-IF:4.1. 

Ye Yan; Feng Li#; Yong‑Hao Gai; Qing‑Wei Liu*: An innovative procedure of laparoscope combined with endoscopy for gastrointestinal stromal tumor resection and cholecystectomy: A case report and literature review, Experimental and Therapeutic Medicine, 2016 Apr;11(4):1393-1398. 中科院四区, 5-IF:2.4. 

单孔腹腔镜腹膜后清创术在感染坏死性胰腺炎治疗中的应用.中华肝胆外科杂志，2020，26（4）：281-285.                          （第一作者） 

感染性坏死性胰腺炎微创“阶梯式”治疗策略.中华肝脏外科手术学电子杂志,2020,9(5):409-413.                                         （第一作者） 

贲门异位支气管源性囊肿1例及文献复习.中国现代普通外科杂志，2022,25（9）：754-756.                                                （通讯作者） 

保留脾脏功能的腹腔镜胰体尾手术—Kimura法的初步探讨.腹腔镜外科杂志，2022,27（3）：165-170.                                        （通讯作者）